IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IPCA Laboratories Ltd (IPCALAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3343
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmintic products, among others. It also provides generic and branded formulations including oral solids and liquids, dry powders for suspension and injectables. IPCA’s products targets various disease areas such as acne, brain disease, fever, pain, malaria, mental illness, urinary disease, stomach ailments, heart ailment and rheumatoid arthritis, among others. It has operations and manufacturing facilities across India, Colombia, Kazakhastan, Sri Lanka, Vietnam, Russia, Kenya, and others. IPCA is headquartered in Mumbai, Maharashtra, India.

IPCA Laboratories Ltd (IPCALAB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Ipca Labs Acquires Oral Solid Dosage Formulations Manufacturing Unit from Alpa Labs for USD11.5 Million 11
Partnerships 12
Nuformix Extends Agreement with Onyx Scientific 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Molecular Profiles Enters Into Agreement With Onyx Scientific 14
Licensing Agreements 15
Ipca Labs Enters into Licensing Agreement with Oncobiologics for ONS-1050 15
Ipca Labs Amends Licensing Agreement with Oncobiologics 16
Debt Offering 17
Ipca Labs Completes Private Placement Of Debentures For US$4 Million 17
Acquisition 18
Ipca Pharma and Onyx Scientific Acquire Pisgah Labs for USD9.6 Million 18
Ipca Laboratories Acquires Additional 26% Stake in Krebs Biochemicals 19
Khazanah Nasional Acquires Minority Stake in Ipca Labs for USD40 Million 20
Ipca Labs To Acquire 50% Stake In Avik Pharma For US$1 Million 21
Ipca Labs Completes Acquisition Of Remaining 67.7% Stake In Tonira Pharma For US$2.2 Million 22
IPCA Laboratories Ltd – Key Competitors 23
IPCA Laboratories Ltd – Key Employees 24
IPCA Laboratories Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Financial Announcements 27
May 29, 2018: Ipca Laboratories: Audited FY18 Financial Results 27
Feb 07, 2018: Ipca Laboratories Q3 FY18 Financial Results 28
Nov 14, 2017: Ipca Laboratories Q2 FY18 Financial Results 29
Aug 11, 2017: Ipca Laboratories Q1 FY18 Unaudited Financial Results 30
May 28, 2017: Ipca Laboratories Audited FY17 Financial Results 31
Legal and Regulatory 32
Jun 20, 2017: IPCA Laboratories: US FDA Update 32
Jun 15, 2017: IPCA Lab Provides Update on SEZ Indore and Piparia Manufacturing Units 33
Jun 15, 2017: IPCA Laboratories Provides Update on Ratlam manufacturing facility 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IPCA Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ipca Labs Acquires Oral Solid Dosage Formulations Manufacturing Unit from Alpa Labs for USD11.5 Million 11
Nuformix Extends Agreement with Onyx Scientific 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Molecular Profiles Enters Into Agreement With Onyx Scientific 14
Ipca Labs Enters into Licensing Agreement with Oncobiologics for ONS-1050 15
Ipca Labs Amends Licensing Agreement with Oncobiologics 16
Ipca Labs Completes Private Placement Of Debentures For US$4 Million 17
Ipca Pharma and Onyx Scientific Acquire Pisgah Labs for USD9.6 Million 18
Ipca Laboratories Acquires Additional 26% Stake in Krebs Biochemicals 19
Khazanah Nasional Acquires Minority Stake in Ipca Labs for USD40 Million 20
Ipca Labs To Acquire 50% Stake In Avik Pharma For US$1 Million 21
Ipca Labs Completes Acquisition Of Remaining 67.7% Stake In Tonira Pharma For US$2.2 Million 22
IPCA Laboratories Ltd, Key Competitors 23
IPCA Laboratories Ltd, Key Employees 24
IPCA Laboratories Ltd, Other Locations 25
IPCA Laboratories Ltd, Subsidiaries 25

List of Figures
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bilcare Ltd (526853):企業の財務・戦略的SWOT分析
    Bilcare Ltd (526853) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomp …
  • Schmolz + Bickenbach AG:企業の戦略・SWOT・財務情報
    Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report Summary Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Arqvia Group Ltd:企業の戦略・SWOT・財務分析
    Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sunningdale Tech Ltd (BHQ):企業の財務・戦略的SWOT分析
    Summary Sunningdale Tech Ltd (Sunningdale) is a chemical company that manufactures and markets tooling and plastic injection moulding components. The company's plastic solutions include product and mould designs, injection moulding, mould fabrication, complementary finishings, and precision assembly …
  • The Eat Out Group, SL:企業の戦略・SWOT・財務情報
    The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report Summary The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Reach Subsea ASA (REACH)-石油・ガス分野:企業M&A・提携分析
    Summary Reach Subsea ASA (Reach) provides engineering consultancy services and advanced remotely-operated underwater vessels (ROV) to the oil industry. The company also offers inspection, maintenance and repair, survey, construction support and decommissioning services. Reach offers multi-support ve …
  • Ritter Pharmaceuticals Inc (RTTR):製薬・医療:M&Aディール及び事業提携情報
    Summary Ritter Pharmaceuticals Inc (Ritter) is a developer of therapeutic products for gastrointestinal diseases. The company’s lead product includes RP-G28, which is developed stimulate the growth of lactose-metabolizing bacteria in the colon to assist in digesting process. Its product is under the …
  • Independent Electricity System Operator:企業の戦略的SWOT分析
    Independent Electricity System Operator - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company. The company produces outdoor power products for forestry, gardening and construction. It offers wheeled products, electric products. Husqvarna also provides handheld products, watering and hand tools, accessories, and construction …
  • Gulf Cement Company PSC:企業の戦略・SWOT・財務情報
    Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report Summary Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析
    Summary Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distr …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Lechwerke AG (LEC):企業の財務・戦略的SWOT分析
    Summary Lechwerke AG (LechWerke), a subsidiary of Innogy SE is a utility service provider that offers electricity products natural gas products and energy services. The company provides services such as electrical safety, gas safety, energy monitoring, power plant contracting, street lighting, energ …
  • Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its products are used for the ther …
  • Continuum Wind Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Continuum Wind Energy Ltd (Continuum Wind Energy), a subsidiary of Morgan Stanley Infrastructure Partners LP is a renewable energy company that constructs and develops wind farms and wind energy generation. The company's services include optimization of number of wind turbines to maximize ge …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆